PRLD
Prelude Therapeutics Incorporated
Set alert
3.88 USD -0.22 -5.37%
3.82 Day range 4.11
1.19 52-week range 6.63
- YTD
- +33.79%
- 1 year
- +147.13%
- Open
- 4.01
- Prev close
- 4.10
- Mkt cap
- 309.02M
- Vol
- 218.10K
- Avg vol
- 494.54K
- EPS
- -0.73
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.82
- High
- 4.11
- Forward P/E
- -0.82
- Beta
- 1.55
- Short ratio
- 7.51
- Inst. own
- 84.98%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 1.23
- 200-d avg
- 3.50
- 1y target
- 5.00
Ownership
Held by insiders 9.36%
Held by institutions 84.98%
Float held by institutions 93.76%
Institutions 101
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 30.14% | 16,589,442 | 20.57M | Sep 29, 2024 |
| Baker Bros. Advisors, LP | 18.40% | 10,123,824 | 12.55M | Sep 29, 2024 |
| Deerfield Management Company, L.P. (Series C) | 6.84% | 3,766,120 | 4.67M | Sep 29, 2024 |
| Boxer Capital, LLC | 3.10% | 1,708,187 | 2.12M | Sep 29, 2024 |
| Price (T.Rowe) Associates Inc | 1.99% | 1,097,599 | 1.36M | Sep 29, 2024 |
| Blackrock Inc. | 1.92% | 1,058,316 | 1.31M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) Health Sciences Fund | 1.47% | 809,844 | 1.00M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 1.31% | 720,427 | 893.33K | Sep 29, 2024 |
| iShares Russell 2000 ETF | 0.65% | 358,702 | 444.79K | Oct 30, 2024 |
| MFS New Discovery Fund | 0.60% | 327,699 | 406.35K | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 0.38% | 207,507 | 257.31K | Sep 29, 2024 |
| Price (T.Rowe) Small-Cap Value Fund | 0.32% | 178,089 | 220.83K | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BONITA DAVID P. M.D. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 21, 2023 | 0 |
| CHARDONNET LAURENT | Chief Financial Officer | Purchase | May 22, 2023 | 42,165 |
| HUANG JANE | President | Conversion of Exercise of derivative security | Oct 3, 2024 | 63,341 |
| LIM BRYANT DAVID | Chief Financial Officer | Purchase | Dec 18, 2024 | 27,400 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 21, 2023 | 0 |
| VADDI KRISHNA | Chief Executive Officer | Purchase | Dec 18, 2024 | 0 |
Held by funds
40 US ETFs and mutual funds hold PRLD · largest positions